P2D Inc.
Records under this name other than patents P2D Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to P2D Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,361,667 | 4′,4″-substituted 3α-(diphenylmethoxy) tropane analogs for treatment of mental disorders Term ended Term ended Mar 1, 2025 · From the USPTO record | Term ended | Term ended Mar 1, 2025 | From the USPTO record |
| US 8,546,430 | Thalidomide analogs Term ended Term ended Sep 17, 2024 · From the USPTO record | Term ended | Term ended Sep 17, 2024 | From the USPTO record |
| US 7,973,057 | Thalidomide Analogs Lapsed on the fee record Ended Jul 5, 2023 · High confidence | Lapsed on the fee record | Ended Jul 5, 2023 | High confidence |
| US 8,853,253 | Thalidomide analogs Lapsed on the fee record Ended Oct 7, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2022 | From the USPTO record |